Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Future Perspectives in the Treatment of Cutaneous T-Cell Lymphoma (CTCL)
Reinhard Dummer
Seminars in Oncology (2006) Vol. 33, pp. 33-36
Closed Access | Times Cited: 21

Showing 21 citing articles:

Malignant Tregs express low molecular splice forms of FOXP3 in Sézary syndrome
Thorbjørn Krejsgaard, Lise Mette Rahbek Gjerdrum, Elisabeth Ralfkiær, et al.
Leukemia (2008) Vol. 22, Iss. 12, pp. 2230-2239
Closed Access | Times Cited: 85
Differential Effects of Interleukin-2 and Interleukin-15 versus Interleukin-21 on CD4+ Cutaneous T-Cell Lymphoma Cells
Michał Marzec, Krzysztof Halasa, Monika Kasprzycka, et al.
Cancer Research (2008) Vol. 68, Iss. 4, pp. 1083-1091
Closed Access | Times Cited: 83
Nonmalignant T cells stimulate growth of T-cell lymphoma cells in the presence of bacterial toxins
Anders Woetmann, Paola Lovato, Karsten W. Eriksen, et al.
Blood (2006) Vol. 109, Iss. 8, pp. 3325-3332
Open Access | Times Cited: 78
IL-2– and IL-15–induced activation of the rapamycin-sensitive mTORC1 pathway in malignant CD4+ T lymphocytes
Michał Marzec, Xiaobin Liu, Monika Kasprzycka, et al.
Blood (2007) Vol. 111, Iss. 4, pp. 2181-2189
Open Access | Times Cited: 71
γc-Signaling Cytokines Induce a Regulatory T Cell Phenotype in Malignant CD4+ T Lymphocytes
Monika Kasprzycka, Qian Zhang, Agnieszka K. Witkiewicz, et al.
The Journal of Immunology (2008) Vol. 181, Iss. 4, pp. 2506-2512
Open Access | Times Cited: 61
The role of cytokine signaling in the pathogenesis of cutaneous T-cell lymphoma
Ronnie M. Abraham, Qian Zhang, Niels Ødum, et al.
Cancer Biology & Therapy (2011) Vol. 12, Iss. 12, pp. 1019-1022
Open Access | Times Cited: 57
Expression profiling of 22 genes involved in the PI3K–AKT pathway identifies two subgroups of high-grade endometrial carcinomas with different molecular alterations
Lluís Catasús, Emanuela D’Angelo, Cristina Pons, et al.
Modern Pathology (2010) Vol. 23, Iss. 5, pp. 694-702
Open Access | Times Cited: 51
Comparison of pegylated interferon α‐2b plus psoralen PUVA versus standard interferon α‐2a plus PUVA in patients with cutaneous T‐cell lymphoma
A.C. Hüsken, Athanasios Tsianakas, Peter Hensen, et al.
Journal of the European Academy of Dermatology and Venereology (2011) Vol. 26, Iss. 1, pp. 71-78
Closed Access | Times Cited: 35
Resistance of Cutaneous Anaplastic Large-Cell Lymphoma Cells to Apoptosis by Death Ligands Is Enhanced by CD30-Mediated Overexpression of c-FLIP
Frank Braun, Burkhard Hirsch, Nadya Al‐Yacoub, et al.
Journal of Investigative Dermatology (2009) Vol. 130, Iss. 3, pp. 826-840
Open Access | Times Cited: 25
Classification and Treatment of Rare and Aggressive Types of Peripheral T-Cell/Natural Killer-Cell Lymphomas of the Skin
Dorna Rezania, Lubomir Sokol, Hernani Cualing
Cancer Control (2007) Vol. 14, Iss. 2, pp. 112-123
Closed Access | Times Cited: 22
An Unusual Case of Granulomatous Slack Skin Disease With Necrobiosis
Emma Clare Benton, Stephen Morris, Alistair Robson, et al.
American Journal of Dermatopathology (2008) Vol. 30, Iss. 5, pp. 462-465
Closed Access | Times Cited: 15
Gene therapy in interventional pulmonology: Interferon gene delivery with focus on thoracic malignancies
Satish Kalanjeri, Daniel H. Sterman
Current Respiratory Care Reports (2012) Vol. 1, Iss. 1, pp. 54-66
Open Access | Times Cited: 3
Detergent fractionation with subsequent subtractive suppression hybridization as a tool for identifying genes coding for plasma membrane proteins
Andreas Lange, Claudia Kistler, Tanja Jutzi, et al.
Experimental Dermatology (2009) Vol. 18, Iss. 6, pp. 527-535
Closed Access | Times Cited: 3
A Dose-Escalation Study of Pegylated Liposomal Doxorubicin and Oxaliplatin in Patients with Advanced Solid Tumors
Athanasios Κotsakis, Ch. Kouroussis, N. Androulakis, et al.
Oncology (2006) Vol. 71, Iss. 3-4, pp. 190-196
Closed Access | Times Cited: 3
T-cell primary cutaneous lymphomas. A clinicopathological and immunohistochemical study.
Irina-Draga Căruntu, Veronica Mardari, Doiniţa Radulescu, et al.
Polish Journal of Pathology (2007) Vol. 58, Iss. 4, pp. 259-65
Closed Access | Times Cited: 2
Interferons: Mechanisms, Biological Activities and Survey of their Use in Human Diseases
Dalia Obeid, Brigitte Bauvois
Current Bioactive Compounds (2006) Vol. 2, Iss. 4
Closed Access | Times Cited: 2
Cutaneous T-cell lymphoma and emerging therapies
Regina Fink‐Puches, Lorenzo Cerroni
Drug Discovery Today Disease Mechanisms (2008) Vol. 5, Iss. 1, pp. e69-e79
Closed Access | Times Cited: 1
Non-malignant T cells stimulate growth of T-cell lympho ma cells in the presence of bacterial toxins Short title: Malignant and non-malignant T c ells cross-talk
Anders Woetmann, Paola Lovato, Karsten W. Eriksen, et al.
(2016)
Closed Access
Pegylated, liposomal doxorubicin in the treatment of primary cutaneous T-cell lymphoma: an update
Stefano Pulini, Serena Rupoli, Gaia Goteri, et al.
Hematology Meeting Reports (formerly Haematologica Reports) (2009) Vol. 3, Iss. 1, pp. 94-95
Closed Access
Current Awareness in Hematological Oncology

Hematological Oncology (2006) Vol. 24, Iss. 3, pp. 166-173
Closed Access
Page 1

Scroll to top